biz profile3.21

With Covid measures winding down further in 3Q2022 in markets that Cordlife Group operates, its in-person interaction with potential clients has been boosted.

Marketing expenses (through participation in baby expos, for example,) have crept up 7.3% y-o-y.

While Cordlife recognises marketing expenses when incurred, it doesn't record revenue when clients sign up but only when their babies are delivered and cord-blood banking services etc are provided.


"Sign-ups tend to happen at the seventh, eighth month when everything's stable and they're just waiting for the babies to be born.

"This time around, we find that probably almost 50% of sign ups are due around that time and the other 50% are due in the next quarter or even later. In July, we had sign-ups who were going to deliver in January," says CEO Tan Poh Lan at a 3Q update briefing.

Baby expo2022In Singapore (July 2022): Parents-to-be in talks with Cordlife staff on the company's services relating to the storing of baby's cord blood and umbilical cord, etc. Singapore is the largest market for Cordlife.

Team11.22Net profit for 3Q2022 came in at $946,000, similar to that for 1Q and 2Q this year, bringing the total to $2.8 million (down 33% y-o-y). 

Profitability is down 46% y-o-y.

Cordlife's sign-ups a year ago, when Covid measures were in place and virtual seminars and outreach were the key business tools, came without the additional marketing expenses associated with in-person events such as expos.

Going forward, marketing expenses are expected to translate into cashflow and profits in the months after the sign-ups.

Stock price 

32 c

52-week range

31 - 42 c



Market cap

S$82 m

Net cash  S$80.4 m



1-year return


Source: Yahoo!

One striking thing about Cordlife's latest balance sheet is the net cash balance amounting to $80.4 million, up by $1.4 million from end-Dec 2021.

Cashflow has continued to be positive as Cordlife requires new clients to pay upfront, or a maximum of 5 years, instead of annually over a period of as long as 21 years. The long duration raises the risk of payment defaults.

In Singapore, the annual option continues to be available as payments are facilitated by direct deductions from clients' Child Development Accounts, says interim CFO Thet Hnin Yi.

Even then, the majority of clients (~75%) in Singapore are paying upfront.







Net profit






Cordlife's cashpile equates to almost the entire market cap ($82 m) of Cordlife shares listed on the Singapore Exchange, an uncommon happening.

It's hard to argue that after accounting for its solid cashpile, Cordlife's operating business is worth only a mere $1.6 million.

Aside from generating consistent cashflow, Cordlife has delivered $6.2 million net profit a year on average since FY18 (see table above).

Perhaps investors need to see, post-Covid, a return to that level of profit or higher -- and maybe even another M&A event -- before re-rating the stock? 

For more info on the 3Q2022 performance, see the presentation deck here. 

Share Prices

Counter NameLastChange
AEM Holdings3.450-0.110
Avi-Tech Electronics0.280-
Best World2.4300.080
Broadway Ind0.1140.006
China Sunsine0.470-0.005
Food Empire0.710-
Fortress Minerals0.360-0.010
Geo Energy Res0.330-0.010
Golden Energy0.790-0.005
GSS Energy0.048-
ISDN Holdings0.570-0.020
IX Biopharma0.122-
Jiutian Chemical0.081-0.002
KSH Holdings0.340-
Leader Env0.062-
Medtecs Intl0.158-0.005
Meta Health0.024-
Nordic Group0.4750.005
Oxley Holdings0.148-
REX International0.225-0.005
Sinostar PEC0.185-
Southern Alliance Mining0.6000.005
Straco Corp.0.5100.010
Sunpower Group0.370-0.010
The Trendlines0.095-0.001
Totm Technologies0.113-
UG Healthcare0.182-0.005
Uni-Asia Group0.8900.015
Wilmar Intl4.100-0.030
Yangzijiang Shipbldg1.250-0.020

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 1382 guests and no members online